The Claim

Inhibition of CAMKKβ using STO-609 eliminates oleuropein aglycone-induced phosphorylation of AMPK and the induction of autophagy in human neuroblastoma cells, indicating that CAMKKβ is a necessary upstream activator in this signaling pathway.

Source: Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
8score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Blocking the CAMKKβ protein prevents oleuropein aglycone from activating AMPK and triggering autophagy in human neuroblastoma cells, showing that CAMKKβ is required for this biochemical process to occur.

See the scientific wording

Inhibition of CAMKKβ with STO-609 abolishes oleuropein aglycone-induced AMPK phosphorylation and autophagy in human neuroblastoma cells, demonstrating that CAMKKβ is a necessary upstream activator in this pathway.

What the research says

1 study
  1. Study: Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight

    The study shows that a compound in olive oil turns on a cellular cleanup process by first activating a specific protein called CAMKKβ. If you block that protein, the cleanup stops — which is exactly what the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.